Publications
- Inhibitor of PCSK9 protein - alirocumab in clinical trials, ODYSSEY program2018 | First Faculty of Medicine
- Combination therapy of risk factors of atherosclerosis in clinical practise2017 | First Faculty of Medicine
- Prevention of cardiovascular diseases in clinical practice: is it possible to achieve improvement?2014 | First Faculty of Medicine
- Hormone replacement therapy from the viewpoint of an internist2010 | First Faculty of Medicine
- Co s pacientem po infarktu myokardu (IM) v ambulanci praktického lékaře? Kdy potřebuje kardiologa?2023 | First Faculty of Medicine
- PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology2022 | First Faculty of Medicine
- Zahájení léčby arteriální hypertenze2022 | First Faculty of Medicine
- Lipid lowering therapy - proven treatment options and prospects for the near future2022 | First Faculty of Medicine
- Treatment of hypercholesterolemia in the Czech Republic - up to date2021 | First Faculty of Medicine
- The treatment of arterial hypertension in patient with myocardial infaction in recent history, the percutaneous coronary intervention is just the beginning2021 | First Faculty of Medicine
Loading network view...